Statistics

Total Visits

Views
Bevacizumab (B) (10 mg/kg) in combination with cisplatin (C) and docetaxel (D) administered every 2 weeks in patients (p) with advanced non-squamous non-Small Cell Lung Cancer (nsNSCLC): GGCP047/10 study8

Select a period of time:

Number of views in the range

Views
Bevacizumab (B) (10 mg/kg) in combination with cisplatin (C) and docetaxel (D) administered every 2 weeks in patients (p) with advanced non-squamous non-Small Cell Lung Cancer (nsNSCLC): GGCP047/10 study7

Views

Views
November 20232
December 20231
January 20241
February 20240
March 20240
April 20241
May 20242
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States7
 

Top cities views

Views
Chicago2
Boardman2
Ashburn1